Fall 2021 | Boston, MA
Pharma Division of Deep Knowledge Analytics has recently launched a new series of proprietary analytics, integrated summaries of which can be reviewed here.
This series currently includes the following 7 reports, which will be updated quarterly and systematically extended by the addition of new special case studies:
– Comparative Industry Analysis and Classification Framework (updated monthly);
– Declining Efficiency of R&D in Pharma Corporations;
– Pharma AI Stock Index;
– Analysis of Leading Investors in the AI for Drug Discovery Sector;
– Top-30 AI-Pharma Analysts;
– Defining Hype vs Reality in AI for Drug Discovery Sector;
– Enhanced Comparative Analysis of Leading AI-startups.
You can read about our analytics methodology here.
We look forward to your feedback, and in case of interest please contact us at firstname.lastname@example.org.
Deep Knowledge Analytics proudly supports the AI Applications in Biopharma Summit.